Related Experiment Video
Updated: Sep 7, 2025
03:38
Unilateral Lung Volume Analysis Using Micro-CT for Enhanced Assessment of Pulmonary Fibrosis in Preclinical Models
Published on: June 20, 2025
321
Post-Coronavirus Disease 2019 Pulmonary Fibrosis: Wait or Needs Intervention
1Division of Allergy and Respiratory Diseases, Soonchunhyang University Seoul Hospital, Seoul, Republic of Korea.
Tuberculosis and Respiratory Diseases
|June 20, 2022
Summary
Pulmonary fibrosis is an increasing complication of COVID-19. This review explores its epidemiology, risk factors, pathogenesis, and management, highlighting the need for clearer definitions and evaluation timelines for this lung scarring condition.
Area of Science:
- Pulmonology
- Infectious Diseases
- Pathology
Background:
- Coronavirus disease 2019 (COVID-19) presents a significant global health challenge.
- While acute management is established, long-term complications like pulmonary fibrosis are increasingly recognized.
- Limited data and consensus exist regarding the definition and evaluation of post-COVID-19 pulmonary fibrosis.
Purpose of the Study:
- To review the current understanding of post-COVID-19 pulmonary fibrosis.
- To investigate its epidemiology, risk factors, and pathogenesis.
- To discuss current and potential management strategies.
Main Methods:
- Literature review of studies on post-COVID-19 pulmonary fibrosis.
- Analysis of epidemiological data, risk factors, and proposed pathogenetic mechanisms.
- Synthesis of information on clinical course and management approaches.
Main Results:
- Pulmonary fibrosis is a common respiratory complication of COVID-19, with increasing prevalence.
- Lesions often show improvement within a year, complicating timely evaluation.
- There is a lack of standardized criteria for defining and assessing this condition.
Conclusions:
- Post-COVID-19 pulmonary fibrosis requires further investigation due to its rising incidence.
- Standardized definitions and evaluation protocols are crucial for accurate diagnosis and management.
- Understanding risk factors and pathogenesis is key to developing effective treatments.
Related Concept Videos
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.7K
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
42
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
42
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.0K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.0K
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.6K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.6K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.9K
01:20COPD: Pathogenesis and Clinical Features
510
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
510